Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Uwe, Kalina"'
Autor:
Christina Kober, Sandro Manni, Svenja Wolff, Thomas Barnes, Shatanik Mukherjee, Thomas Vogel, Lea Hoenig, Peter Vogel, Aaron Hahn, Michaela Gerlach, Martin Vey, Eleonora Widmer, Björn Keiner, Patrick Schuetz, Nathan Roth, Uwe Kalina
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
Analysis of convalescent plasma derived from individuals has shown that IgG3 has the most important role in binding to SARS-CoV-2 antigens; however, this has not yet been confirmed in large studies, and the link between binding and neutralization has
Externí odkaz:
https://doaj.org/article/0a986c6c0236457e90ae747e192debc8
Publikováno v:
Journal of Thrombosis and Haemostasis
Summary Essentials Performance of the one‐stage clotting (OSC) assay varies with the clotting activator used.Recombinant FIX‐albumin fusion protein (rIX‐FP) was reliably monitored with most OSC reagents.rIX‐FP shows comparable reagent‐depen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::143c7491c98936ca9ca224ac6b9aa6c4
https://doi.org/10.1111/jth.14332
https://doi.org/10.1111/jth.14332
Autor:
Aaron Hahn, Uwe Kalina, Thomas Hauser, Daniel Filchtinski, Nathan J. Roth, Patrick Schuetz, Thomas W. Barnes, Michelle R. Williams, Johannes Schulte-Pelkum, Christina Kober, Laura Steller, Robin Jenness, Toby L. Simon, Sandro Manni
Publikováno v:
Clinical Immunology Society
Clinical Immunology (Orlando, Fla.)
Clinical Immunology (Orlando, Fla.)
Despite the burgeoning field of coronavirus disease-19 (COVID-19) research, the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralising antibodies remains unclear. This study validated two high-throughput immunologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::498695e34d72f9f0a627cc8270d40150
Publikováno v:
Allergy and asthma proceedings. 41(2)
Background: Replacement therapy with plasma-derived C1-inhibitor (C1-INH) has been used for decades to treat patients with hereditary angioedema (HAE) with C1-INH deficiency. Objective: This article reviewed the rationale for using C1-INH replacement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19907de13c768e7247e318f5b881bfd9
https://pubmed.ncbi.nlm.nih.gov/31796151
https://pubmed.ncbi.nlm.nih.gov/31796151
Autor:
Alex Veldman, Debra M. Bensen-Kennedy, Kenneth D. Friedman, Hubert Metzner, Nicole Blackman, C. Horn, A. Stowers, K. St. Ledger, Annette Feussner, Uwe Kalina
Publikováno v:
Journal of Thrombosis and Haemostasis. 16:555-564
Essentials AFSTYLA exhibits ≈50% underestimation in activity when the one-stage (OS) assay is utilized. A field study compared the performance of AFSTYLA with Advate in factor VIII activity assays. AFSTYLA activity can be monitored with both the ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2b68cb0699253e3f434ab670267b50e
https://doi.org/10.1111/jth.13932
https://doi.org/10.1111/jth.13932
Autor:
Nathan J. Roth, Birgit Popp, Karlheinz Enssle, Thomas Nowak, Uwe Kalina, Albrecht Gröner, Wolfram Schäfer
Publikováno v:
Transfusion. 57:1184-1191
BACKGROUND Beriplex P/N/Kcentra/Coaplex/Confidex is a four-factor human prothrombin complex concentrate (PCC). Here, we describe the pathogen safety profile and biochemical characteristics of an improved manufacturing process that further enhances th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cb5de4a8d7d55122a4394a9b192bd6a
https://doi.org/10.1111/trf.14010
https://doi.org/10.1111/trf.14010
Autor:
Thomas, Nowak, Birgit, Popp, Albrecht, Gröner, Wolfram, Schäfer, Uwe, Kalina, Karlheinz, Enssle, Nathan J, Roth
Publikováno v:
Transfusion. 57(5)
Beriplex P/N/Kcentra/Coaplex/Confidex is a four-factor human prothrombin complex concentrate (PCC). Here, we describe the pathogen safety profile and biochemical characteristics of an improved manufacturing process that further enhances the virus saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::84d86ca1e335d8039b5e363cd60ac1ba
https://pubmed.ncbi.nlm.nih.gov/28191640
https://pubmed.ncbi.nlm.nih.gov/28191640
Publikováno v:
International Journal of Clinical Practice. 62:1614-1622
Summary Aims: A number of prothrombin complex concentrates (PCCs) are commercially available but they differ in terms of composition. We performed a series of studies to compare the biochemical properties of seven PCCs. Methods: The following product
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4862c7338af51d1bb9ac3496860cbe6
https://doi.org/10.1111/j.1742-1241.2008.01859.x
https://doi.org/10.1111/j.1742-1241.2008.01859.x
Autor:
Sigurd Knaub, A. Nagy, Helmut Ostermann, Uwe Kalina, Benjamin Brenner, Beriplex® P, Ingrid Pabinger
Publikováno v:
Journal of Thrombosis and Haemostasis. 6:622-631
Summary. Background: Prothrombin complex concentrate (PCC) can substantially shorten the time needed to reverse antivitamin K oral anticoagulant therapy (OAT). Objectives. To determine the effectiveness and safety of emergency OAT reversal by a balan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482a3bdbe73566747c00f3d0a5326f22
https://doi.org/10.1111/j.1538-7836.2008.02904.x
https://doi.org/10.1111/j.1538-7836.2008.02904.x
Publikováno v:
Shock. 21:139-143
The interaction of antithrombin III (AT) with cell surface glycosaminoglycans is known to have an inhibitory effect on inflammatory processes. We evaluated the effect of AT on endotoxin-induced production of oxygen radical in the pulmonary circulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ef3bfd5cbd3a9397e586b38b8004630
https://doi.org/10.1097/01.shk.0000104267.15342.6b
https://doi.org/10.1097/01.shk.0000104267.15342.6b